| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -36.36M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AVTX returned +100.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +9.2% |
| 1 year | +100.7% |
| 5 years | -99.8% |
| 10 years | -99.8% |
| All-time high | $20,620.80 (Feb 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AVTX would be worth today ›No. Avalo Therapeutics, Inc. has not paid a dividend in the past 12 months.
Avalo Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol AVTX.
Avalo Therapeutics, Inc. is part of the Healthcare sector.
Avalo Therapeutics, Inc. has a market cap of 1.06B USD, based on the latest quote.
